Characteristics and outcomes of COVID-19 patients presumed to be treated with sotrovimab in NHS hospitals in England
Abstract Background The impact of the constantly evolving severe acute respiratory syndrome coronavirus 2 on the effectiveness of early coronavirus disease 2019 (COVID-19) treatments is unclear. Here, we report characteristics and acute clinical outcomes of patients with COVID-19 treated with a mono...
Enregistré dans:
| Auteurs principaux: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMC
2024-04-01
|
| Collection: | BMC Infectious Diseases |
| Sujets: | |
| Accès en ligne: | https://doi.org/10.1186/s12879-024-09311-2 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|